Non-invasive hemodynamic assessment in patients with pulmonary hypertension Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008
Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010
Prognostic predictors in younger and older incident idiopathic pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology Year: 2013
Hospitalization in patients with pulmonary arterial hypertension: causes and outcomes Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009
Exercise ventilatory inefficiency is an independent predictor of mortality in patients with pulmonary arterial hypertension Source: Annual Congress 2012 - Limiting factors in exercise Year: 2012
Noninvasive identification of left-sided heart failure in a population suspected of pulmonary arterial hypertension Source: Eur Respir J 2015; 46: 422-430 Year: 2015
Preoperative pulmonary risk assessment of pulmonary arterial hypertension in patients undergoing cardiac surgery Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010
Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020
Survival and prognostic factors of acute exacerbations of pulmonary arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 342s Year: 2007
Usefulness of FVC/DLCO ratio to stratify the risk of mortality in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016
Noninvasive cardiac output measurements in patients with pulmonary hypertension Source: Eur Respir J 2013; 42: 125-133 Year: 2013
Age, risk and outcomes in idiopathic pulmonary arterial hypertension Source: Eur Respir J, 51 (5) 1800629; 10.1183/13993003.00629-2018 Year: 2018
Cardiovascular complications of invasive hemodynamic evaluation in patients with pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010
Risk stratification and medical therapy of pulmonary arterial hypertension Source: Eur Respir J, 53 (1) 1801889; 10.1183/13993003.01889-2018 Year: 2019
Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension Source: Eur Respir J, 51 (5) 1702310; 10.1183/13993003.02310-2017 Year: 2018
Noncardiothoracic nonobstetric surgery in mild-to-moderate pulmonary hypertension Source: Eur Respir J 2010; 35: 1294-1302 Year: 2010
Novel biomarkers for risk stratification in pulmonary arterial hypertension Source: ERJ Open Res 2015; 1: 00008-2015 Year: 2015
Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018 Year: 2019
Biochemical predictors of mortality in pulmonary embolism Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism Year: 2011
Early improvements predict outcomes in pulmonary arterial hypertension Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension Year: 2018